The Pathogenicity Analysis of a Hypogonadotropic Hypogonadism Patient With the Novel Variant in the Deep Intronic Region of the PROK2 Gene
Molecular Genetics & Genomic Medicine · 2026-07 · 14 (7)
DOI: 10.1002/mgg3.70267 ↗Kurz gefasst
Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 14.07.2026. Verfasst von Jiali Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Luoyang Key Laboratory of Clinical Multiomics and Translational Medicine, Key Laboratory of Hereditary Rare Diseases of Health Commission of Henan Pr…. Hauptthemen laut MEDLINE: Hypogonadism, Neuropeptides. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Key Project of Science and Technology Research and Development Joint Fund of Henan Province in China, the Henan Medical Education Research Project.
Abstract (Originalsprache)
Background
Isolated hypogonadotropic hypogonadism (IHH) is a rare endocrine disorder caused by genes such as ANOSI (OMIM*300836), FGFR1 (OMIM*136350), PROK2 (OMIM*607002) and PROKR2 (OMIM*607123) (etc.), leading to downstream dysfunction of pituitary gonadotropin secretion and subsequent impairment of gonadal function. Clinical manifestations include incomplete or partial puberty and infertility. Methods and Results In this study, whole‐genome sequencing of a female patient with HH identified a novel 5′ splice site variant c.285 + 772 T>G in the deep intron of PROK2 (NM_001126128.2). In vitro minigene validation revealed abnormal splicing of this variant, with 69 base pairs retained in intron 3, ultimately leading to changes in protein length, which may lead to changes in protein structure. According to the American College of Medical Genetics and Genomics (ACMG) pathogenicity classification, this variant is rated as likely pathogenic variant (LP).
Conclusion
PROK2 variants can lead to HH and we report a case with a novel splice site variant that has been confirmed to lead to the retention of 69 base pairs in intron 3 during RNA splicing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Luoyang Key Laboratory of Clinical Multiomics and Translational Medicine, Key Laboratory of Hereditary Rare Diseases of Health Commission of Henan Province, Henan Key Laboratory of Rare Diseases, Endocrinology and Metab…
ORCID-Profile: Jiali Chen, Yujin Ma, Liping Li, Huifang Peng, Hongwei Jiang
Förderung
- the Key Project of Science and Technology Research and Development Joint Fund of Henan Province in China
- the Henan Medical Education Research Project
Zitieren
APA
Chen, J., Ma, Y., Li, L., Peng, H., & Jiang, H. (2026). The Pathogenicity Analysis of a Hypogonadotropic Hypogonadism Patient With the Novel Variant in the Deep Intronic Region of the PROK2 Gene. Molecular Genetics & Genomic Medicine, 14(7). https://doi.org/10.1002/mgg3.70267
Vancouver
Chen J, Ma Y, Li L, Peng H, Jiang H. The Pathogenicity Analysis of a Hypogonadotropic Hypogonadism Patient With the Novel Variant in the Deep Intronic Region of the PROK2 Gene. Molecular Genetics & Genomic Medicine. 2026;14(7). doi:10.1002/mgg3.70267
BibTeX
@article{Chen2026,
author = {Chen, Jiali and Ma, Yujin and Li, Liping and Peng, Huifang and Jiang, Hongwei},
title = {The Pathogenicity Analysis of a Hypogonadotropic Hypogonadism Patient With the Novel Variant in the Deep Intronic Region of the PROK2 Gene},
journal = {Molecular Genetics & Genomic Medicine},
year = {2026},
volume = {14},
number = {7},
doi = {10.1002/mgg3.70267}
}
EUVIMED